MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MXCT is expected to report earnings to rise 3.13% to -8 cents per share on November 11
Q3'26
Est.
$-0.08
Q2'26
Est.
$-0.08
Q1'26
Beat
by $0.04
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 182.88K shares outstanding, the current market capitalization sits at 142.42M.